Expression of secretory phospholipase A2 in colon tumor cells potentiates tumor growth

Molecular Carcinogenesis

Volumn 46, Issue 2, 2007, Pages 106-116

  Belinsky, Glenn S ^a   Rajan, Thiruchandurai V ^b   Saria, Elizabeth A ^a   Giardina, Charles ^c   Rosenberg, Daniel W ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^b UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

Adenocarcinoma; Arachidonic acid; Mouse; Secretory phospholipase A2; Tumor modifiers; Tumorigenesis

Indexed keywords

ARACHIDONIC ACID; ARACHIDONIC ACID DERIVATIVE; BUTYRIC ACID; CALCIUM; PALMITIC ACID DERIVATIVE; PALMITOYLARACHIDONOYLPHOSPHATIDIC ACID; PHOSPHATIDIC ACID; PHOSPHOLIPASE A2; PLASMID VECTOR; RECEPTOR; UNCLASSIFIED DRUG;

ALLELE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CALCIUM BINDING; CANCER INFILTRATION; CANCER INHIBITION; CARCINOGENESIS; CELL DEATH; CELL DIVISION; COLON CARCINOMA; COLON TUMOR; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME RELEASE; ENZYME SUBSTRATE; EXPLANT; GENE MUTATION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; INTESTINE TUMOR; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; RECEPTOR BINDING; TUMOR CELL LINE; TUMOR GROWTH; TUMOR VOLUME;

ARACHIDONIC ACID; BASE SEQUENCE; BUTYRIC ACID; CELL DIVISION; CELL LINE, TUMOR; COLONIC NEOPLASMS; DNA PRIMERS; HUMANS; PHOSPHOLIPASES A; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

MURINAE; MUS; MUS MUSCULUS;

EID: 33847056171     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.20271     Document Type: Article

References (49)

1. Dragani TA. 10 years of mouse cancer modifier loci: Human relevance. Cancer Res 2003;63:3011-3018.
2. MacPhee M, Chepenik KP, Liddell RA, Nelson KK, Siracusa LD, Buchberg AM. The secretory phospholipase A2 gene is a candidate for the Mom1 locus, a major modifier of ApcMin-induced intestinal neoplasia. Cell 1995;81:957-966.
3. Cormier RT, Hong KH, Halberg RB, et al. Secretory phospholipase Pla2g2a confers resistance to intestinal tumorigenesis. Nat Genet 1997;17:88-91.
4. Dietrich WF, Lander ES, Smith JS, et al. Genetic identification of Mom-1, a major modifier locus affecting Min-induced intestinal neoplasia in the mouse. Cell 1993;75:631-639.
5. Papanikolaou A, Wang QS, Mulherkar R, Bolt A, Rosenberg DW. Expression analysis of the group IIA secretory phospholipase A(2) in mice with differential susceptibility to azoxymethane-induced colon tumorigenesis. Carcinogenesis 2000;21:133-138.
6. Kennedy BP, Payette P, Mudgett J, et al. A natural disruption of the secretory group II phospholipase A2 gene in inbred mouse strains. J Biol Chem 1995;270:22378-22385.
7. Kennedy BP, Soravia C, Moffat J, et al. Overexpressionof the nonpancreatic secretory group II PLA2 messenger RNA and protein in colorectal adenomas from familial adenomatous polyposis patients. Cancer Res 1998;58:500-503.
8. Wendum D, Svrcek M, Rigau V, et al. COX-2, inflammatory secreted PLA2, and cytoplasmic PLA2 protein expression in small bowel adenocarcinomas compared with colorectal adenocarcinomas. Mod Pathol 2003;16:130-136.
9. Atsumi G, Murakami M, Tajima M, Shimbara S, Hara N, Kudo I. The perturbed membrane of cells undergoing apoptosis is susceptible to type II secretory phospholipase A2 to liberate arachidonic acid. Biochim Biophys Acta 1997;1349:43-54.
10. Heirman I, Ginneberge D, Brigelius-Flohe R, et al. Blocking tumor cell eicosanoid synthesis by GP × 4 impedes tumor growth and malignancy. Free Radic Biol Med 2006;40:285-294.
11. Sonoshita M, Takaku K, Sasaki N, et al. Acceleration of intestinal polyposis through prostaglandin receptor EP2 in Apc(Delta 716) knockout mice. Nat Med 2001;7:1048-1051.
12. Chan TA, Morin PJ, Vogelstein B, Kinzler KW. Mechanisms underlying nonsteroidal antiinflammatory drug-mediated apoptosis. Proc Natl Acad Sci USA 1998;95:681-686.
13. Ilsley JN, Nakanishi M, Flynn C, et al. Cytoplasmic phospholipase A2 deletion enhances colon tumorigenesis. Cancer Res 2005;65:2636-2643.
14. Wolf LA, Laster SM. Characterization of arachidonic acid-induced apoptosis. Cell Biochem Biophys 1999;30:353-368.
15. Harwig SS, Tan L, Qu XD, Cho Y, Eisenhauer PB, Lehrer RI. Bactericidal properties of murine intestinal phospholipase A2. J Clin Invest 1995;95:603-610.
16. Qu XD, Lehrer RI. Secretory phospholipase A2 is the principal bactericide for staphylococci and other gram-positive bacteria in human tears. Infect Immun 1998;66:2791-2797.
17. Weinrauch Y, Abad C, Liang NS, Lowry SF, Weiss J. Mobilization of potent plasma bactericidal activity during systemic bacterial challenge. Role of group HA phospholipase A2. J Clin Invest 1998;102:633-638.
18. Weinrauch Y, Elsbach P, Madsen LM, Foreman A, Weiss J. The potent anti-Staphylococcus aureus activity of a sterile rabbit inflammatory fluid is due to a 14-kD phospholipase A2. J Clin Invest 1996;97:250-257.
19. Mulherkar R, Saraf A, Wagle A, Deo MG. Purification of the enhancing factor from mouse intestines. FEBS Lett 1986;207:142-144.
20. Mulherkar R, Desai SJ, Rao RS, Wagle AS, Deo MG. Expression of enhancing factor gene and its localization in mouse tissues. Histochemistry 1991;96:367-370.
21. Cupillard L, Mulherkar R, Gomez N, et al. Both group IB and group IIA secreted phospholipases A2 are natural ligands of the mouse 180-kDa M-type receptor. J Biol Chem 1999;274:7043-7051.
22. Hernandez M, Burillo SL, Crespo MS, Nieto ML. Secretory phospholipase A2 activates the cascade of mitogen-activated protein kinases and cytosolic phospholipase A2 in the human astrocytoma cell line 1321N1. J Biol Chem 1998;273:606-612.
23. Hernandez M, Fuentes L, Fernandez Aviles FJ, Crespo MS, Nieto ML. Secretory phospholipase A(2) elicits proinflammatory changes and upregulates the surface expression of fas ligand in monocytic cells: Potential relevance for atherogenesis. Circ Res 2002;90:38-45.
24. Belinsky GS, Claffey KP, Nambiar PR, Guda K, Rosenberg DW. Vascular endothelial growth factor and enhanced angiogenesis do not promote metastatic conversion of a newly established azoxymethane-induced colon cancer cell line. Mol Carcinog 2005;43:65-74.
25. Milovic V, Teller IC, Faust D, Caspary WF, Stein J. Effects of deoxycholate on human colon cancer cells: Apoptosis or proliferation. Eur J Clin Invest 2002;32:29-34.
26. Murakami M, Nakatani Y, Kudo I. Type II secretory phospholipase A2 associated with cell surfaces via C-terminal heparin-binding lysine residues augments stimulus-initiated delayed prostaglandin generation. J Biol Chem 1996;271:30041-30051.
27. Radvanyi F, Jordan L, Russo-Marie F, Bon C. A sensitive and continuous fluorometric assay for phospholipase A2 using pyrene-labeled phospholipids in the presence of serum albumin. Anal Biochem 1989;177:103-109.
28. Harlow E, Lane D. Antibodies. Cold Spring Harbor: Cold Spring Harbor Laboratory; 1988.
29. Markova M, Koratkar RA, Silverman KA, et al. Diversity in secreted PLA(2)-IIA activity among inbred mouse strains that are resistant or susceptible to Apc(Min/+) tumorigenesis. Oncogene 2005;24:6450-6458.
30. Lambeau G, Ancian P, Nicolas JP, et al. Structural elements of secretory phospholipases A2 involved in the binding to M-type receptors. J Biol Chem 1995;270:5534-5540.
31. Perez R, Matabosch X, Llebaria A, Balboa MA, Balsinde J. Blockade of arachidonic acid incorporation into phospholipids induces apoptosis in U937 promonocytic cells. J Lipid Res 2006;47:484-491.
32. Hague A, Manning AM, Hanlon KA, Huschtscha LI, Hart D, Paraskeva C. Sodium butyrate induces apoptosis in human colonic tumour cell lines in a p53-independent pathway: Implications for the possible role of dietary fibre in the prevention of large-bowel cancer. Int J Cancer 1993;55:498-505.
33. McBain JA, Eastman A, Nobel CS, Mueller GC. Apoptotic death in adenocarcinoma cell lines induced by butyrate and other histone deacetylase inhibitors. Biochem Pharmacol 1997;53:1357-1368.
34. Tsujii M, DuBois RN. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell 1995;83:493-501.
35. Dong M, Guda K, Nambiar PR, et al. Inverse association between phospholipase A2 and COX-2 expression during mouse colon tumorigenesis. Carcinogenesis 2003;24:307-315.
36. Dong M, Johnson M, Rezaie A, et al. Cytoplasmic phospholipase A2 levels correlate with apoptosis in human colon tumorigenesis. Clin Cancer Res 2005;11:2265-2271.
37. Hershko DD, Robb BW, Wray CJ, Luo GJ, Hasselgren PO. Superinduction of IL-6 by cycloheximide is associated with mRNA stabilization and sustained activation of p38 map kinase and NF-kappaB in cultured caco-2 cells. J Cell Biochem 2004;91:951-961.
38. Choi YA, Lim HK, Kim JR, et al. Group IB secretory phospholipase A2 promotes matrix metalloproteinase-2-mediated cell migration via the phosphatidylinositol 3-kinase and Akt pathway. J Biol Chem 2004;279:36579-36585.
39. Singh J, Rivenson A, Tomita M, Shimamura S, Ishibashi N, Reddy BS. Bifidobacterium longum, a lactic acid-producing intestinal bacterium inhibits colon cancer and modulates the intermediate biomarkers of colon carcinogenesis. Carcinogenesis 1997;18:833-841.
40. Yamazaki K, Tsunoda A, Sibusawa M, et al. The effect of an oral administration of Lactobacillus casei strain shirota on azoxymethane-induced colonic aberrant crypt foci and colon cancer in the rat. Oncol Rep 2000;7:977-982.
41. Graff JR, Konicek BW, Deddens JA, et al. Expression of group IIa secretory phospholipase A2 increases with prostate tumor grade. Clin Cancer Res 2001;7:3857-3861.
42. Jiang J, Neubauer BL, Graff JR, et al. Expression of group IIA secretory phospholipase A2 is elevated in prostatic intraepithelial neoplasia and adenocarcinoma. Am J Pathol 2002;160:667-671.
43. Lagorce-Pages C, Paraf F, Wendum D, Martin A, Flejou JF. Expression of inflammatory secretory phospholipase A2 and cytosolic phospholipase A2 in premalignant and malignant Barrett's oesophagus. Virchows Arch 2004;444:426-435.
44. Masuda S, Murakami M, Ishikawa Y, Ishii T, Kudo I. Diverse cellular localizations of secretory phospholipase A2 enzymes in several human tissues. Biochim Biophys Acta 2005;1736:200-210.
45. Aggarwal A, Guo DL, Hoshida Y, et al. Topological and functional discovery in a gene coexpression meta-network of gastric cancer. Cancer Res 2006;66:232-241.
46. Behrens J, Lustig B. The Wnt connection to tumorigenesis. Int J Dev Biol 2004;48:477-487.
47. Mulherkar R, Kirtane BM, Ramchandani A, Mansukhani NP, Kannan S, Naresh KN. Expression of enhancing factor/phospholipase A2 in skin results in abnormal epidermis and increased sensitivity to chemical carcinogenesis. Oncogene 2003;22:1936-1944.
48. Park DW, Kim JR, Kim SY, et al. Akt as a mediator of secretory phospholipase A2 receptor-involved inducible nitric oxide synthase expression. J Immunol 2003;170:2093-2099.
49. Khaleghpour K, Li Y, Banville D, Yu Z, Shen SH. Involvement of the PI 3-kinase signaling pathway in progression of colon adenocarcinoma. Carcinogenesis 2004;25:241-248.